汉森制药：10mg规格的恩格列净片目前已生产销售

Core Viewpoint - Hansen Pharmaceutical has commenced the production and sale of 10mg empagliflozin tablets, which are indicated for the treatment of type 2 diabetes and symptomatic chronic heart failure in adults, aimed at reducing the risk of hospitalization due to heart failure. The impact of this product on the company's performance in the second half of the year remains uncertain [1] Group 1 - The 10mg empagliflozin tablets are now available for sale [1] - The product is intended for two specific medical conditions: type 2 diabetes and symptomatic chronic heart failure [1] - The company has not provided clarity on how this product will affect its financial performance in the latter half of the year [1]